RICHMOND, Va. & MONTREAL & BUDE, England--(BUSINESS WIRE)--Tripos Discovery Research (TDR) Limited, a wholly owned subsidiary within the Commonwealth Biotechnologies, Inc. (CBI) group of companies (NASDAQ Capital Market:CBTE) and a leading provider of drug discovery chemistry services and small molecule products, announces today that it has secured a milestone payment from Gemin X Biotechnologies Inc., a biopharmaceutical company specializing in the discovery and development of novel small molecule cancer therapeutics.
